Galectin-1 is up-regulated by RASSF1A gene in human gastric carcinoma cell line SGC7901

APMIS

Volumn 120, Issue 7, 2012, Pages 582-590

  Zheng Hao, Deng ^a   Ji Fang, Wen ^a   De Sheng, Xiao ^a   Jian Hua, Zhou ^a  

^a Central South University   (China)

Author keywords

Galectin 1; Proteomics

Indexed keywords

BETA ACTIN; CD79A ANTIGEN; DIAZEPAM BINDING INHIBITOR; GALECTIN 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROTEIN PSMB4; PROTEIN PSMB5; PROTEIN TIM; PROTEIN TRP 14; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; VIMENTIN;

AMINO ACID SEQUENCE; ARTICLE; BIOINFORMATICS; CANCER CELL CULTURE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RASSF1A GENE; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GALECTIN 1; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84862646838     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2012.02874.x     Document Type: Article

References (31)

1. Crew KD, Neugut AI. Epidemiology of gastric cancer. World J Gastroenterol 2006;12:354-62.
2. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-9. 4.
3. Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005;65:3497-508.
4. Ye M, Xia B, Guo Q, Zhou F, Zhang X. Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China. BMC Cancer 2007;7:120.
5. Wang YC, Yu ZH, Liu C, Xu LZ, Yu W, Lu J, et al. Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients. World J Gastroenterol 2008;14:3074-80.
6. Deng ZH, Wen JF, Li JH, Xiao DS, Zhou JH. Activator protein-1 involved in growth inhibition by RASSF1A gene in the human gastric carcinoma cell line SGC7901. World J Gastroenterol 2008;14:1437-43.
7. Richter AM, Pfeifer GP, Dammann RH. The RASSF proteins in cancer; from epigenetic silencing to functional characterization. Biochim Biophys Acta 2009;1796:114-28.
8. Ahmed-Choudhury J, Agathanggelou A, Fenton SL, Ricketts C, Clark GJ, Maher ER, et al. Transcriptional regulation of cyclin A2 by RASSF1A through the enhanced binding of p120E4F to the cyclin A2 promoter. Cancer Res 2005;65:2690-7.
9. Whang YM, Kim YH, Kim JS, Yoo YD. RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res 2005;65:3682-90.
10. Thaler S, Hähnel PS, Schad A, Dammann R, Schuler M. RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res 2009;69:1748-57.
11. Deng ZH, Cao HQ, Hu YB, Wen JF, Zhou JH. TRX is up-regulated by fibroblast growth factor-2 in lung carcinoma. APMIS 2011;119:57-65.
12. Bo LI, De-Yun F, Rui-Xue C, Shu-Yan S, Qiong-Qiong H, Zhong-Liang H, et al. The mechanisms for HCV NS3 protein upregulating cell proliferation in human hepatocytes. Prog Biochem Biophys 2005;32:991-7.
13. Feng X-P, Yi H, Li M-Y, Li X-H, Yi B, Zhang P-F, et al. Identification of biomarkers for predicting nasopharyngeal carcinoma response to radiotherapy by proteomics. Cancer Res 2010;70:3450-62.
14. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001;93:691-9.
15. Verma SK, Ganesan TS, Kishore U, Parker PJ. The tumor suppressor RASSF1A is a novel effector of small G protein Rap1A. Protein Cell 2011;2:237-49.
16. Guo C, Zhang X, Pfeifer GP. The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2. J Biol Chem 2011;286:6253-61.
17. Jeong W, Yoon HW, Lee SR, Rhee SG. Identification and characterization of TRP14, a thioredoxin-related protein of 14 kDa. J Biol Chem 2004;279:3142-50.
18. Jeong W, Chang TS, Boja ES, Fales HM, Rhee SG. Roles of TRP14, a thioredoxin-related protein in tumor necrosis factor-asignaling pathways. J Biol Chem 2004;279:3151-9.
19. Whang YM, Kim YH, Kim JS, Yoo YD. RASSF1A suppresses the c-Jun-NH2-kinase pathway and inhibits cell cycle progression. Cancer Res 2005;65:3682-90.
20. Schroeder F, Petrescu AD, Huang H, Atshaves BP, McIntosh AL, Martin GG, et al. Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids 2008;43:1-17.
21. Lee BC, Cha K, Avraham S, Avraham HK. Microarray analysis of differentially expressed genes associated with human ovarian cancer. Int J Oncol 2004;24:847-51.
22. Gossett RE, Schroeder F, Gunn JM, Kier AB. Expression of fatty acyl-CoA binding proteins in colon cells: response to butyrate and transformation. Lipids 1997;32:577-85.
23. Camby I, Mercier ML, Lefranc F, Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006;16:137R-57R.
24. Thijssen VL, Barkan B, Shoji H, Aries IM, Mathieu V, Deltour L, et al. Tumor cells secrete galectin-1 to enhance endothelial cell activity. Cancer Res 2010;70:6216-24.
25. Paz A, Haklai R, Elad-Sfadia G, Ballan E, Kloog Y. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 2001;20:7486-93.
26. Demydenko D, Berest I. Expression of galection-1 in malignant tumors. Exp Oncol 2009;31:74-9.
27. Rabinovich GA. Galectin-1 as a potential cancer target. Br J Cancer 2005;92:1188-92.
28. Bektas S, Bahadir B, Ucan BH, Ozdamar SO. CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance. Pathol Oncol Res. 2010;16:569-77.
29. Satelli A, Subrahmanyeswara Rao U. Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells. Cancer Lett 2011;301:38-46.
30. Sanchez-Ruderisch H, Detjen KM, Welzel M, André S, Fischer C, Gabius H-J, et al. Galectin-1 sensitizes carcinoma cells to anoikis via the fibronectin receptora5b1-integrin. Cell Death Differ 2011;18:806-16.
31. Fischer C, Sanchez-Ruderisch H, Welzel M, Wiedenmann B, Sakai T, André S, et al. Galectin-1 Interacts with theα5β1Fibronectin Receptor to Restrict Carcinoma Cell Growth via Induction of p21 and p27. J Biol Chem 2005;280:37266-77.